Showing 1471-1480 of 10595 results for "".
Navigating Today and Shaping Tomorrow in ISM: Personalized Strategies With Current and Emerging KIT Inhibitors
https://reachmd.com/programs/cme/navigating-today-and-shaping-tomorrow-in-ism-personalized-strategies-with-current-and-emerging-kit-inhibitors/54388/Explore the latest clinical evidence on current and emerging KIT tyrosine kinase inhibitors in indolent systemic mastocytosis to optimize patient care.Navigating KDIGO Practice Guideline Recommendations to Maximize Proteinuria Reduction in Patients With IgAN
https://reachmd.com/programs/cme/navigating-upated-kdigo-clinical-practice-guideline-recommndations-to-maximize-proteinuria-reduction-in-patients-with-igan/26630/Explore updated KDIGO guideline recommendations and clinical strategies to reduce proteinuria in patients with IgA nephropathy.The Cell Death Pathway: Leveraging Glioblastoma Treatments
https://reachmd.com/programs/neurofrontiers/the-cell-death-pathway-leveraging-glioblastoma-treatments/15111/What role does nutrition have in treating patients with glioblastoma? Tune in for details on a new cell death pathway that could potentially treat tumor cells.Physician, Patient, Minister: One Woman's Three Lenses on Egg Freezing
https://reachmd.com/programs/primary-care-today/physician-patient-minister-one-womans-three-lenses-egg-freezing/8189/Dr. Lisa Ashe describes her personal experience with egg freezing from three simultaneous vantage points: physician, patient, and minister.Updated Target Blood Sugar Levels for Type 2 Diabetes Patients
https://reachmd.com/programs/what-your-patients-are-talking-about/updated-target-blood-sugar-levels-type-2-diabetes-patients/7387/According to a report in the New England Journal of Medicine, doctors now have updated targets for lowering blood sugar in their Type 2 diabetes patients.Patient Perspective: Navigating TGCT Treatment—Surgery vs Systemic Therapy
https://reachmd.com/programs/cme/patient-perspective-navigating-tgct-treatmentsurgery-vs-systemic-therapy/48911/Explore TGCT recognition, clinical evidence, treatment strategies, and management of adverse events with CSF1R inhibitors in an interdisciplinary context.The Future of Customized Treatments Within the Atopic Dermatitis Pipeline
https://reachmd.com/programs/dermatology-hub-neuroimmune-network/the-future-of-customized-treatments-within-the-atopic-dermatitis-pipeline/37165/Practical Dermatology Editorial Board member Peter Lio, MD, a Clinical Assistant Professor of Dermatology and Pediatrics at Northwestern University Feinberg School of Medicine, discusses the potential impact of new developments in atopic dermatitis research.Future Directions in Psoriasis Treatment: Innovations and Implications
https://reachmd.com/programs/frontlines-psoriasis/future-directions-in-psoriasis-treatment-innovations-and-implications/32439/Dr. Andrew Blauvelt shares his insights on the evolving treatment landscape for psoriasis, from novel oral therapies to biologic injections.Uncovering Evidence on Blood Pressure Improvements in Americans
https://reachmd.com/programs/heart-matters/uncovering-evidence-on-blood-pressure-improvements-in-americans/11976/Emerging research has revealed that blood pressure among adults in the U.S. has decreased. Learn more about these surprising results.Lengthening Telomeres?
https://reachmd.com/programs/what-your-patients-are-talking-about/lengthening-telomeres/7168/Dr. McDonough discusses an interesting report in The Lancet Oncology regarding telomeres.